Aerosolized amphotericin B in prophylaxis of pulmonary aspergillosis

被引:0
|
作者
Tsourounis, C
Guglielmo, BJ
机构
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:1175 / 1176
页数:2
相关论文
共 50 条
  • [21] Efficacy of Combination Antifungal Therapy with Intraperitoneally Administered Micafungin and Aerosolized Liposomal Amphotericin B against Murine Invasive Pulmonary Aspergillosis
    Takazono, Takahiro
    Izumikawa, Koichi
    Mihara, Tomo
    Kosai, Kosuke
    Saijo, Tomomi
    Imamura, Yoshifumi
    Miyazaki, Taiga
    Seki, Masafumi
    Kakeya, Hiroshi
    Yamamoto, Yoshihiro
    Yanagihara, Katsunori
    Kohno, Shigeru
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (08) : 3508 - 3510
  • [22] Nebulized amphotericin B combined with intravenous amphotericin B in rats with severe invasive pulmonary aspergillosis
    Ruijgrok, EJ
    Fens, MHAM
    Bakker-Woudenberg, IAJM
    van Etten, EWM
    Vulto, AG
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (05) : 1852 - 1854
  • [23] Safety of aerosolized amphotericin B
    Knechtel, Stephanie A.
    Klepser, Michael E.
    EXPERT OPINION ON DRUG SAFETY, 2007, 6 (05) : 523 - 532
  • [24] Inhaled amphotericin B lipid complex for prophylaxis against COVID-19-associated invasive pulmonary aspergillosis
    María Cruz Soriano
    Gabriela Narváez-Chávez
    Marina López-Olivencia
    Jesús Fortún
    Raúl de Pablo
    Intensive Care Medicine, 2022, 48 : 360 - 361
  • [25] Inhaled amphotericin B lipid complex for prophylaxis against COVID-19-associated invasive pulmonary aspergillosis
    Soriano, Maria Cruz
    Narvaez-Chavez, Gabriela
    Lopez-Olivencia, Marina
    Fortun, Jesus
    de Pablo, Raul
    INTENSIVE CARE MEDICINE, 2022, 48 (03) : 360 - 361
  • [26] Characterization of amphotericin B aerosols for inhalation treatment of pulmonary aspergillosis
    Roth, C
    Gebhart, J
    JustNubling, G
    vonEisenhartRothe, B
    BeinhauerReeb, I
    INFECTION, 1996, 24 (05) : 354 - 360
  • [27] Efficacy and safety of generic amphotericin B in experimental pulmonary aspergillosis
    Petraitis, V
    Petraitiene, R
    Lin, PX
    Calis, K
    Kelaher, AM
    Muray, HA
    Mya-San, C
    Mickiene, D
    Bacher, J
    Walsh, TJ
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (04) : 1642 - 1645
  • [28] AMPHOTERICIN-B IN TREATMENT OF SAPROPHYTIC FORMS OF PULMONARY ASPERGILLOSIS
    HAMMERMAN, KJ
    SAROSI, GA
    TOSH, FE
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1974, 109 (01): : 57 - 62
  • [29] Impact of liposomal amphotericin B therapy on chronic pulmonary aspergillosis
    Newton, Pippa J.
    Harris, Chris
    Morris, Julie
    Denning, David W.
    JOURNAL OF INFECTION, 2016, 73 (05) : 485 - 495
  • [30] USE OF AMPHOTERICIN-B AEROSOLS FOR THE PREVENTION OF PULMONARY ASPERGILLOSIS
    BEYER, J
    SCHWARTZ, S
    BARZEN, G
    RISSE, G
    DULLENKOPF, K
    WEYER, C
    SIEGERT, W
    INFECTION, 1994, 22 (02) : 143 - 148